Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450*
暂无分享,去创建一个
Haoming Zhang | L. Waskell | D. Hamdane | S. Im | Jung‐Ja P. Kim | Djemel Hamdane | Lucy Waskell | Chuanwu Xia | Sang-Choul Im | Jung-Ja P. Kim | Haoming Zhang | C. Xia
[1] M. J. Coon,et al. Kinetics of reduction of cytochrome P-450LM4 in a reconstituted liver microsomal enzyme system. , 1979, The Journal of biological chemistry.
[2] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[3] M. J. Coon,et al. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase. , 1981, The Journal of biological chemistry.
[4] C. Kasper,et al. Determination of the rate of reduction of oxyferrous cytochrome P450 2B4 by 5-deazariboflavin adenine dinucleotide T491V cytochrome P450 reductase. , 2003, Biochemistry.
[5] L. Waskell,et al. Cytochrome b5 Increases the Rate of Product Formation by Cytochrome P450 2B4 and Competes with Cytochrome P450 Reductase for a Binding Site on Cytochrome P450 2B4* , 2007, Journal of Biological Chemistry.
[6] R. Gray. Kinetics and mechanism of carbon monoxide binding to purified liver microsomal cytochrome P-450 isozymes. , 1982, The Journal of biological chemistry.
[7] M. Gerstein,et al. The morph server: a standardized system for analyzing and visualizing macromolecular motions in a database framework. , 2000, Nucleic acids research.
[8] R. Banerjee,et al. Human Methionine Synthase Reductase, a Soluble P-450 Reductase-like Dual Flavoprotein, Is Sufficient for NADPH-dependent Methionine Synthase Activation* , 2001, The Journal of Biological Chemistry.
[9] C. Wolf,et al. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] Christopher C. Moser,et al. Natural engineering principles of electron tunnelling in biological oxidation–reduction , 1999, Nature.
[11] H. Enoch,et al. Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. , 1979, The Journal of biological chemistry.
[12] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[13] S. Kelly,et al. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. , 2006, Structure.
[14] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[15] M. J. Coon,et al. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH. , 1982, The Journal of biological chemistry.
[16] V. Blinov,et al. Cytochrome C (Fe2+) as a competitive inhibitor of NADPH-dependent reduction of cytochrome P450 LM2: locating protein-protein interaction sites in microsomal electron carriers. , 1992, Archives of biochemistry and biophysics.
[17] T. Iyanagi,et al. Redox properties of the reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 and reduced nicotinamide adenine dinucleotide-cytochrome b5 reductases. , 1974, Biochemistry.
[18] G. Kurzban,et al. Preparation and characterization of FAD-dependent NADPH-cytochrome P-450 reductase. , 1986, The Journal of biological chemistry.
[19] Nico P E Vermeulen,et al. Enzyme-Catalyzed Activation of Anticancer Prodrugs , 2004, Pharmacological Reviews.
[20] G. Tollin,et al. Laser flash photolysis studies of the reduction kinetics of NADPH:cytochrome P-450 reductase. , 1991, Biochemistry.
[21] L. Waskell,et al. Overexpression and purification of the membrane-bound cytochrome P450 2B4. , 2001, Protein expression and purification.
[22] C. Kasper,et al. Role of Acidic Residues in the Interaction of NADPH-Cytochrome P450 Oxidoreductase with Cytochrome P450 and Cytochrome c(*) , 1995, The Journal of Biological Chemistry.
[23] C. Wolf,et al. Cloning and Characterization of a Novel Human Dual Flavin Reductase* , 2000, The Journal of Biological Chemistry.
[24] P. Dutton,et al. Large scale domain movement in cytochrome bc(1): a new device for electron transfer in proteins. , 2001, Trends in biochemical sciences.
[25] M. J. Coon,et al. Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase. , 1978, The Journal of biological chemistry.
[26] Mark Gerstein,et al. The Database of Macromolecular Motions: new features added at the decade mark , 2005, Nucleic Acids Res..
[27] B. Horecker. TRIPHOSPHOPYRIDINE NUCLEOTIDE-CYTOCHROME c REDUCTASE IN LIVER , 1950 .
[28] M. Haque,et al. A connecting hinge represses the activity of endothelial nitric oxide synthase , 2007, Proceedings of the National Academy of Sciences.
[29] T. Poulos,et al. Structure of a cytochrome P450-redox partner electron-transfer complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] N. Scrutton,et al. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding. , 2002, Biochemistry.
[31] B. Masters,et al. Immunochemical evidence for an association of heme oxygenase with the microsomal electron transport system. , 1972, The Journal of biological chemistry.
[32] C. Bonfils,et al. Activation volume and energetic properties of the binding of CO to hemoproteins. , 1994, Biophysical journal.
[33] Aaron D. Wilson,et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] Zhiping Weng,et al. Protein-protein docking: overview and performance analysis. , 2008, Methods in molecular biology.
[35] C. Kasper,et al. NADPH-Cytochrome P450 Oxidoreductase , 2001, The Journal of Biological Chemistry.
[36] T. E. Wilson,et al. Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. , 1989, The Journal of biological chemistry.
[37] S. Snyder,et al. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991, Nature.
[38] J. Tainer,et al. Structural Basis for Isozyme-specific Regulation of Electron Transfer in Nitric-oxide Synthase*[boxs] , 2004, Journal of Biological Chemistry.
[39] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[40] J. Schenkman,et al. Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners. , 1986, Molecular pharmacology.
[41] B. Masters,et al. The history, properties, and function of NADPH-cytochrome P-450 reductase. , 1980, Pharmacology & therapeutics.
[42] A. Gutiérrez,et al. Conformational dynamics and the energetics of protein--ligand interactions: role of interdomain loop in human cytochrome P450 reductase. , 2007, Biochemistry.
[43] Benveniste,et al. Cytochrome P450 , 1993, Handbook of Experimental Pharmacology.
[44] A. Brunger. Version 1.2 of the Crystallography and NMR system , 2007, Nature Protocols.
[45] I. Vakser,et al. Identification of the Binding Site on Cytochrome P450 2B4 for Cytochrome b 5 and Cytochrome P450 Reductase* , 1998, The Journal of Biological Chemistry.
[46] R. Hille,et al. Differences in a Conformational Equilibrium Distinguish Catalysis by the Endothelial and Neuronal Nitric-oxide Synthase Flavoproteins* , 2008, Journal of Biological Chemistry.